QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

FOR THE QUARTER ENDED SEPTEMBER 30, 2002March 31, 2003

Commission file number 1-1463

UNION CARBIDE CORPORATION
(Exact name of registrant as specified in its charter)

New York
(State or other jurisdiction of
incorporation or organization)
 13-1421730
(I.R.S. Employer Identification No.)


39 Old Ridgebury Road, Danbury, Connecticut 06817-0001

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:203-794-2000


Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o.

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes o    No ý.

At September 30, 2002,March 31, 2003, 1,000 shares of common stock were outstanding, all of which were held by the registrant's parent, The Dow Chemical Company.

The registrant meets the conditions set forth in General Instructions H(1)(a) and (b) for Form 10-Q and is therefore filing this form with a reduced disclosure format.




UNION CARBIDE CORPORATION


TABLE OF CONTENTSUnion Carbide Corporation
Table of Contents

 
 PAGE

PART I—FINANCIAL INFORMATION

 

 
 
Item 1. Financial Statements

 

3
  
Consolidated Statements of IncomeOperations

 

3
  
Consolidated Balance Sheets

 

4
  
Consolidated Statements of Cash Flows

 

5
  
Consolidated Statements of Comprehensive Income

 

6
  
Notes to the Consolidated Financial Statements

 

7
 
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

1416
  
Disclosure Regarding Forward-Looking Information

 

1416
  
Results of Operations

 

1416
  
Other Matters

 

1619
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

1822
 
Item 4. Controls and Procedures

 

1823

PART II—OTHER INFORMATION


 
Item 1. Legal Proceedings

 

1923
 
Item 6. Exhibits and Reports on Form 8-K

 

1923

SIGNATURESIGNATURES

 

2024

CERTIFICATIONS

 

2125

EXHIBIT INDEX

 

2327

2



PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS


Union Carbide Corporation and Subsidiaries
Consolidated Statements of IncomeOperations



 Three Months Ended
 Nine Months Ended
 
 Three Months Ended
 
In millions (Unaudited)

In millions (Unaudited)

 Sept. 30,
2002

 Sept. 30,
2001

 Sept. 30,
2002

 Sept. 30,
2001

 In millions (Unaudited)

 March 31,
2003

 March 31,
2002

 
Net trade sales $96 $827 $328 $3,529 Net trade sales $93 $142 
Net sales to related companies 1,083 350 3,116 880 Net sales to related companies 1,196 977 
 
 
 
 
   
 
 
Total Net SalesTotal Net Sales 1,179 1,177 3,444 4,409 Total Net Sales 1,289 1,119 
 
 
 
 
   
 
 
Cost of sales 1,036 1,114 3,059 4,139 Cost of sales 1,308 1,007 
Research and development expenses 26 32 88 112 Research and development expenses 25 32 
Selling, general and administrative expenses 10 31 37 138 Selling, general and administrative expenses 10 14 
Amortization of intangibles 1 1 3 8 Amortization of intangibles 1 2 
Merger-related expenses and restructuring 13  13 1,262 Equity in earnings of nonconsolidated affiliates 10 3 
Insurance company operations, pretax loss  (2)  (3)Sundry income (expense)—net (15) (3)
Equity in earnings of nonconsolidated affiliates 17 19 19 42 Interest income 2 15 
Sundry income (expense)—net (16) 7 14 31 Interest expense and amortization of debt discount 34 33 
Interest income 4 3 31 7   
 
 
Interest expense and amortization of debt discount 33 45 99 143 
 
 
 
 
 
Income (Loss) before Income Taxes and Minority Interests 65 (19) 209 (1,316)
 
 
 
 
 
Income (Loss) before Income TaxesIncome (Loss) before Income Taxes (92) 46 
Provision (Credit) for income taxes 32 (8) 81 (476)  
 
 
Minority interests' share in income  1 1 4 Provision (Credit) for income taxes (33) 9 
 
 
 
 
   
 
 
Net Income (Loss) Available for Common StockholderNet Income (Loss) Available for Common Stockholder $33 $(12)$127 $(844)Net Income (Loss) Available for Common Stockholder $(59)$37 
 
 
 
 
   
 
 
DepreciationDepreciation $77 $91 $230 $302 Depreciation $79 $76 
 
 
 
 
   
 
 
Capital ExpendituresCapital Expenditures $27 $16 $56 $75 Capital Expenditures $19 $9 
 
 
 
 
   
 
 

See Notes to the Consolidated Financial Statements.

3



Union Carbide Corporation and Subsidiaries
Consolidated Balance Sheets

In millions (Unaudited)

In millions (Unaudited)

 Sept. 30,
2002

 Dec. 31,
2001

 In millions (Unaudited)

 March 31,
2003

 Dec. 31,
2002

 
AssetsAssets     Assets 
Current AssetsCurrent Assets     Current Assets     
Cash and cash equivalents $27 $25 
Cash and cash equivalents $30 $35 Accounts and notes receivable:     
Accounts and notes receivable:      Trade (net of allowance for doubtful receivables—2003: $4; 2002: $7) 68 72 
 Trade (net of allowance for doubtful receivables—2002: $9; 2001: $8) 73 266  Related companies 582 756 
 Related companies 496 1,324  Other 124 134 
 Other 261 197 Inventories 188 219 
Inventories 362 363 Deferred income tax assets—current 188 134 
Deferred income tax assets—current 272 299 Asbestos-related insurance receivables—current 110 80 
 
 
   
 
 
Total current assets 1,494 2,484 Total current assets 1,287 1,420 
 
 
   
 
 
InvestmentsInvestments     Investments     
Investments in related companies, at cost 462 480 Investments in related companies 461 461 
Investments in nonconsolidated affiliates 513 565 Investments in nonconsolidated affiliates 513 539 
Other investments 54 24 Other investments 41 39 
Noncurrent receivables 358 253 Noncurrent receivables 28 28 
Noncurrent receivables from related companies 18 587 Noncurrent receivables from related companies  17 
 
 
   
 
 
Total investments 1,405 1,909 Total investments 1,043 1,084 
 
 
   
 
 
PropertyProperty     Property     
Property 7,698 7,711 Property 7,516 7,523 
Less accumulated depreciation 5,057 4,873 Less accumulated depreciation 5,065 4,978 
 
 
   
 
 
Net property 2,641 2,838 Net property 2,451 2,545 
 
 
   
 
 
Other AssetsOther Assets     Other Assets     
Goodwill 26 26 Goodwill 26 26 
Other intangible assets (net of accumulated amortization—2002: $196; 2001: $191) 25 28 Other intangible assets (net of accumulated amortization—2003: $115; 2002: $114) 22 23 
Deferred income tax assets—noncurrent 239 324 Deferred income tax assets—noncurrent 900 756 
Deferred charges and other assets 421 299 Asbestos-related insurance receivables—noncurrent 1,415 1,489 
 
 
 Deferred charges and other assets 107 71 
Total other assets 711 677   
 
 
 
 
 Total other assets 2,470 2,365 
 
 
 
Total AssetsTotal Assets $6,251 $7,908 Total Assets $7,251 $7,414 
 
 
   
 
 
Liabilities and Stockholder's EquityLiabilities and Stockholder's Equity     Liabilities and Stockholder's Equity 
Current LiabilitiesCurrent Liabilities     Current Liabilities     
Notes payable:     
Notes payable:      Related companies $276 $310 
 Related companies $202 $396  Other 10 6 
 Other 3 14 Long-term debt due within one year 380 380 
Long-term debt due within one year 380 15 Accounts payable:     
Accounts payable:      Trade 288 285 
 Trade 224 360  Related companies 349 297 
 Related companies 221 1,197  Other 26 33 
 Other 52 83 Income taxes payable 74 67 
Income taxes payable 39 44 Asbestos-related liabilities—current 147 124 
Accrued and other current liabilities 301 201 Accrued and other current liabilities 218 226 
 
 
   
 
 
Total current liabilities 1,422 2,310 Total current liabilities 1,768 1,728 
 
 
   
 
 
Long-Term DebtLong-Term Debt 1,288 1,730 Long-Term Debt 1,288 1,288 
 
 
   
 
 
Other Noncurrent LiabilitiesOther Noncurrent Liabilities     Other Noncurrent Liabilities     
Pension and other postretirement benefits—noncurrent 638 709 Pension and other postretirement benefits—noncurrent 633 636 
Other noncurrent obligations 908 1,035 Asbestos-related liabilities—noncurrent 1,998 2,072 
 
 
 Other noncurrent obligations 526 597 
Total other noncurrent liabilities 1,546 1,744   
 
 
 
 
 Total other noncurrent liabilities 3,157 3,305 
 
 
 
Minority Interest in SubsidiariesMinority Interest in Subsidiaries 4 7 Minority Interest in Subsidiaries 4 4 
 
 
   
 
 
Stockholder's EquityStockholder's Equity     Stockholder's Equity     
Common stock (1,000 shares authorized and issued)   Common stock (1,000 shares authorized and issued)   
Additional paid-in capital   Additional paid-in capital   
Retained earnings 2,069 2,200 Retained earnings 1,374 1,433 
Accumulated other comprehensive loss (78) (83)Accumulated other comprehensive loss (340) (344)
 
 
   
 
 
Net stockholder's equity 1,991 2,117 Net stockholder's equity 1,034 1,089 
 
 
   
 
 
Total Liabilities and Stockholder's EquityTotal Liabilities and Stockholder's Equity $6,251 $7,908 Total Liabilities and Stockholder's Equity $7,251 $7,414 
 
 
   
 
 

See Notes to the Consolidated Financial Statements.

4



Union Carbide Corporation and Subsidiaries
Consolidated Statements of Cash Flows



 Nine Months Ended
 
 Three Months Ended
 
In millions (Unaudited)

In millions (Unaudited)

 Sept. 30,
2002

 Sept. 30,
2001

 In millions (Unaudited)

 March 31,
2003

 March 31,
2002

 
Operating ActivitiesOperating Activities     Operating Activities     
Net Income (Loss) Available for Common Stockholder $127 $(844)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:     
 Depreciation and amortization 246 299 
 Provision (Credit) for deferred income tax 91 (225)
 Earnings/losses of nonconsolidated affiliates less than (in excess of) dividends received 35 (33)Net Income (Loss) Available for Common Stockholder $(59)$37 
 Minority interests' share in income 1 4 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:     
 Net loss on sale of consolidated company 2   Depreciation and amortization 85 81 
 Net gain on sales of property (17)   Credit for deferred income tax (199) (12)
 Other net gain (30) (26) Earnings/losses of nonconsolidated affiliates less than dividends received 38 42 
 Merger-related expenses and restructuring  951  Net loss (gain) on sales of property 14 (2)
 Tax benefit—nonqualified stock option exercises  4  Other net loss 1 2 
Changes in assets and liabilities that provided (used) cash:     Changes in assets and liabilities that provided (used) cash:     
 Accounts and notes receivable 137 277  Accounts and notes receivable (19) 243 
 Related company receivables 828 (965) Related company receivables 174 91 
 Inventories 1 220  Inventories 31 21 
 Accounts payable (155) (443) Accounts payable 11 (152)
 Related company payables (976) 722  Related company payables 52 (420)
 Other assets and liabilities (218) (247)��Other assets and liabilities (92) (92)
 
 
   
 
 
Cash provided by (used in) operating activities 72 (306)Cash provided by (used in) operating activities 37 (161)
 
 
   
 
 
Investing ActivitiesInvesting Activities     Investing Activities     
Capital expenditures (56) (75)Capital expenditures (19) (9)
Proceeds from sales of property 29 4 Proceeds from sales of property  2 
Proceeds from sale of consolidated company 20  Investments in nonconsolidated affiliates (8) (7)
Investments in nonconsolidated affiliates (18) (7)Collection of noncurrent note receivable from related company 17  
Advances to nonconsolidated affiliates, net of cash received  (106)Purchases of investments  (15)
Collection of noncurrent note receivable from related company 483  Proceeds from sales of investments 5 15 
Proceeds from sale of nonconsolidated affiliate  180   
 
 
Purchases of investments (28) (122)Cash used in investing activities (5) (14)
Proceeds from sales of investments 28 165   
 
 
 
 
 
Cash provided by investing activities 458 39 
 
 
 
Financing ActivitiesFinancing Activities     Financing Activities     
Changes in short-term notes payable (5) (952)
Changes in notes payable to related companies (194) 1,214 
Payments on long-term debt (76) (5)
Purchases of treasury stock  (1)Changes in short-term notes payable 4 (2)
Proceeds from sales of common stock  6 Changes in notes payable to related companies (34) 189 
Distributions to minority interests (3)  Payments on long-term debt  (14)
Dividends paid to stockholder (257) (28)Distributions to minority interests  (1)
 
 
   
 
 
Cash provided by (used in) financing activities (535) 234 Cash provided by (used in) financing activities (30) 172 
 
 
   
 
 
Effect of Exchange Rate Changes on CashEffect of Exchange Rate Changes on Cash   Effect of Exchange Rate Changes on Cash   
 
 
   
 
 
SummarySummary     Summary     
Decrease in cash and cash equivalents (5) (33)Increase (Decrease) in cash and cash equivalents 2 (3)
Cash and cash equivalents at beginning of year 35 63 Cash and cash equivalents at beginning of year 25 35 
 
 
   
 
 
Cash and cash equivalents at end of period $30 $30 Cash and cash equivalents at end of period $27 $32 
 
 
   
 
 

See Notes to the Consolidated Financial Statements.

5



Union Carbide Corporation and Subsidiaries
Consolidated Statements of Comprehensive Income



 Three Months Ended
 Nine Months Ended
 
 Three Months Ended
 
In millions (Unaudited)

In millions (Unaudited)

 Sept. 30,
2002

 Sept. 30,
2001

 Sept. 30,
2002

 Sept. 30,
2001

 In millions (Unaudited)

 March 31,
2003

 March 31,
2002

 
Net Income (Loss) Available for Common StockholderNet Income (Loss) Available for Common Stockholder $33 $(12)$127 $(844)Net Income (Loss) Available for Common Stockholder $(59)$37 
 
 
 
 
   
 
 
Other Comprehensive Income (Loss), Net of TaxOther Comprehensive Income (Loss), Net of Tax         Other Comprehensive Income (Loss), Net of Tax     
Unrealized losses on investments  (4) (5) (7)Unrealized gains on investments 2  
Translation adjustments  32 10 (6)Translation adjustments 2 (4)
 
 
 
 
   
 
 
Total other comprehensive income (loss)  28 5 (13)Total other comprehensive income (loss) 4 (4)
 
 
 
 
   
 
 
Comprehensive Income (Loss)Comprehensive Income (Loss) $33 $16 $132 $(857)Comprehensive Income (Loss) $(55)$33 
 
 
 
 
   
 
 

See Notes to the Consolidated Financial Statements.

6



Union Carbide Corporation and Subsidiaries
Notes to the Consolidated Financial Statements

(Unaudited)

Note A—Consolidated Financial StatementsNOTE A    CONSOLIDATED FINANCIAL STATEMENTS

        Except as otherwise indicated by the context, the terms "Corporation" and "UCC" as used herein mean Union Carbide Corporation and its consolidated subsidiaries. The unaudited interimaccompanying consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) which, in the opinion of management, are considered necessary for a fair presentation of the resultsCorporation include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which the Corporation exercises control. Intercompany transactions and balances are eliminated in consolidation. Investments in nonconsolidated affiliates (20-50 percent owned companies) are accounted for on the periods covered.equity basis.

        Since February 6, 2001, the Corporation has been a wholly owned subsidiary of The Dow Chemical Company ("Dow") as a consequence of the Corporation merging with a wholly owned subsidiary of Dow effective that date (the "merger" or "Dow merger"). Transactions with the Corporation's parent company, Dow, or other Dow subsidiaries have been reflected as related company transactions in the consolidated financial statements. See Note DH for further discussion. In accordance with Statement of Financial Accounting Standards ("SFAS") No. 128, "Earnings Per Share," the presentation of earnings per share is not required in financial statements of wholly owned subsidiaries.

        The Corporation's business activities comprise components of Dow's global operations rather than stand-alone operations. The Corporation sells its products to Dow at market-based prices, in accordance with Dow's longstanding intercompany pricing policy, in order to simplify the customer interface process. Dow conducts its worldwide operations through global businesses. Because there are no separable reportable business segments for UCC under SFAS No. 131, "Disclosures about Segments of an Enterprise and Related Information," and no detailed business information is provided to a chief operating decision maker regarding the Corporation's stand-alone operations, the Corporation's results are reported as a single operating segment.

        Since February 7, 2001, the Corporation has been included in Dow's consolidated federal income tax group and consolidated income tax return. The Corporation uses the separate return method to account for its income taxes; accordingly, there is no difference between the method used to account for income taxes at the UCC level and the formula used to compute the amount due to Dow for UCC's share of income taxes due on Dow's consolidated income tax return.

Certain reclassifications of prior years'year's amounts have been made to conform to the presentation adopted for 2002.2003. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Corporation's Annual Report on Form 10-K filed by the Corporation on March 20, 2002 for the year ended December 31, 2001.2002.

Note B—Accounting ChangesNOTE B    ACCOUNTING CHANGES

        TheIn June 2001, the Financial Accounting Standards Board ("FASB") issued SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities," in June 1998. SFAS No. 133 requires an entity to recognize all derivatives as either assets or liabilities in the statement of financial position and measure those instruments at fair value. The Corporation adopted SFAS No. 133, as amended and interpreted by the FASB and the Derivatives Implementation Group through "Statement 133 Implementation Issues", on January 1, 2001. Due to the Corporation's limited use of financial instruments to manage its exposure to market risks, primarily related to changes in foreign currency exchange rates, the adoption of SFAS No. 133 did not have a material impact on the Corporation's consolidated financial statements.

        In September 2000, the FASB issued SFAS No. 140, "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities." This statement, which replaces SFAS No. 125, revises the standards for accounting for securitizations and other transfers of financial assets and collateral, and requires certain disclosures, but it carries over most of the provisions of SFAS No. 125 without reconsideration. SFAS No. 140 was effective for transfers and servicing of financial assets and extinguishments of liabilities occurring after March 31, 2001. It was effective for recognition and reclassifications of collateral and for disclosures relating to securitization transactions and collateral for fiscal years ending after December 15, 2000. The adoption of SFAS No. 140 did not have a material impact on the Corporation's consolidated financial statements.

        In July 2001, the FASB issued SFAS No. 141, "Business Combinations," which replaces Accounting Principles Board ("APB") Opinion No. 16, "Business Combinations." Under SFAS No. 141, all business combinations

7



initiated after June 30, 2001 are accounted for using the purchase method. The application of SFAS No. 141 did not result in the reclassification of any amounts previously recorded as goodwill or other intangible assets.

        In July 2001, the FASB issued SFAS No. 142, "Goodwill and Other Intangible Assets," which replaces APBreplaced Accounting Principles Board ("APB") Opinion No. 17, "Intangible Assets," and establishesestablished new accounting and reporting requirements for goodwill and other intangible assets, effective for fiscal years beginning after December 15, 2001. Under this statement, goodwill and intangible assets that are deemed to have indefinite useful lives are not amortized, but are subject to impairment testing. Impairment testing iswas required to be performed at adoption and at least annually thereafter. On an ongoing basis (absent any impairment indicators), Dow's global businesses plan to performthe annual impairment teststest is performed during the fourth quarter of each year, in conjunction with the nnualannual budgeting process. Effective January 1, 2002 UCC ceased all amortization of goodwill, which is its only intangible asset with an indefinite useful life, and tested recorded goodwill for impairment by comparing the fair value of each reporting unit, determined using a discounted cash flow method, with its carrying value. The results of the Corporation's goodwill impairment test indicated no impairment.

As required by SFAS No. 142, the Corporation also reassessed the useful lives and the classification of its identifiable intangible assets and determined them to be appropriate. See Note E for additional disclosures regarding the adoption of SFAS No. 142.related to other intangible assets.

7



        In AugustJune 2001, the FASB issued SFAS No. 143, "Accounting for Asset Retirement Obligations," which requires an entity to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred and a corresponding increase in the related long-lived asset. The liability is adjusted to its present value each period and the asset is depreciated over its useful life. A gain or loss may be incurred upon settlement of the liability. SFAS No. 143 is effective for fiscal years beginning after June 15, 2002. The Corporation is currently assessing the impactadoption of adopting this statement.

        In August 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets," which replaces SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of," and provisions of APB Opinion No. 30, "Reporting the Results of Operations—Reporting the Effects of Disposal of143 did not have a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions," for the disposal of segments of a business. The statement creates one accounting model, basedmaterial impact on the framework established in SFAS No. 121, to be applied to all long-lived assets including discontinued operations. SFAS No. 144 is effective for fiscal years beginning after December 15, 2001. The Corporation determined that its current accounting policy for the impairment of long-lived assets is consistent with SFAS No. 144.Corporation's consolidated financial statements.

        In June 2002, the FASB issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities," which nullifies Emerging Issues Task Force Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity." This statement, which iswas effective for exit or disposal activities initiated after December 31, 2002, will changechanges the measurement and timing of costs associated with exit and disposal activities undertaken by the Corporation in the future.

        On August 26, 2002, Dow announced that inIn the first quarter of 2003, it would begin expensing stock options issued to employees in accordance withDow adopted the fair value provisions of SFAS No. 123, "Accounting for Stock-Based Compensation.Compensation," Dow currently uses the accounting method prescribed by APB Opinion No. 25, "Accounting for Stock Issuednew grants of equity instruments to Employees," as allowed by SFAS No. 123; however, expensing stock options is considered the preferable method of accounting for stock-based compensation. In the announcement, Dow stated it expected the expense associated with stock options to be approximately $0.02 per share in 2003, growing to approximately $0.06 per share in 2005. The estimates were based on the current guidance of SFAS No. 123, the terms of Dow's stock option plans and current assumptions for stock option grants and valuation, which may change in the future.employees. The Corporation will beis allocated the portion of expense relating to its employees who receive stock options.stock-based compensation. This allocation was not material to the consolidated financial statements for the first quarter of 2003.

        In November 2002, the FASB issued FASB Interpretation ("FIN") No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others." FIN No. 45 clarifies the requirements of SFAS No. 5, "Accounting for Contingencies," relating to the guarantor's accounting for and disclosures of certain guarantees issued. The initial recognition and measurement provisions of the interpretation are applicable on a prospective basis to guarantees issued or modified after December 31, 2002, irrespective of the guarantor's fiscal year-end. The disclosure requirements of the interpretation are effective for financial statements of interim or annual periods ending after December 15, 2002. The Corporation's disclosures related to guarantees can be found in Note F.

        In January 2003, the FASB issued FIN No. 46, "Consolidation of Variable Interest Entities." FIN No. 46 clarifies the application of Accounting Research Bulletin No. 51, "Consolidated Financial Statements," to certain entities in which equity investors do not have the characteristics of a controlling financial interest or in which equity investors do not bear the residual economic risks. The interpretation applies to variable interest entities ("VIEs") created after January 31, 2003, and to VIEs in which an enterprise obtains an interest after that date. It applies in the fiscal year or interim period beginning after June 15, 2003, to VIEs in which an enterprise holds a variable interest that was acquired before February 1, 2003. See Note G for disclosures regarding the Corporation's VIE and the expected impact of adoption in the third quarter of 2003.

Note C—NOTE C    MERGER-RELATED EXPENSES AND RESTRUCTURING

Merger-related Expenses and Restructuring

        On March 29,Following the completion of the Dow merger in February 2001, management made certain decisions relative to employment levels, duplicate assets and facilities and excess capacity resulting from the Dow merger. These decisions were based on management's assessment of the actions necessary to achieve synergies as a result of the merger. The economic effects of these decisions, combined with merger-related transaction costs and certain asset impairments, resulted in a pretax special charge in the first quarter of 2001 of $1,275 million which was reduced by $52 million in subsequent quarters of 2001.

8



        The special charge included $629 million for employee-related costs, which consisted predominantly of provisions for employee severance, change of control obligations, medical and retirement benefits, and outplacement services. The charge was increased by $3 million during 2001 as the original estimates of amounts expected to be paid were further refined. The integration plans included a workforce reduction of approximately 4,200 people. The charge for severance was based upon the severance plan provisions communicated to employees. According to the initial integration plans, the Corporation expected to expend approximately 66 percent of the employee-related costs within the first two years following the merger, though the timing of severance payments is dependent upon employee elections. Expenditures with respect to employee-related costs associated with pension and postretirement benefit plans will occur over a much more extended period. As of December 31, 2001, severance of approximately $327 million had been paid to approximately 2,900 former employees. In the first three quarters of 2002, severance of $91 million was paid to approximately 1,030 former employees, bringing the program-to-date amount to $418 million paid to approximately 3,930 former employees.million. The planned merger-related program for workforce reductions was substantially completed in the third quarter of 2002. Complete disclosures related to the program and the activity in the merger-related special charge reserve can be found in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2002.

8



        During the fourth quarter of 2002, althoughan additional charge of $34 million was recorded for merger-related severance. Under this revised severance program, $55 million was paid to 668 former employees in the first quarter of 2003.

        Additional reductions in headcount may continue as the Corporation continues its restructuring efforts. The Corporation will account for future workforce reductions as they occur.

        The special charge included $41 million for transaction costs, which consisted primarily of investment banking, legal and accounting fees. All of these costs had been paid at March 31, 2001.Other Restructuring

        The special charge included $605 million for the write-down of duplicate assets and facilities directly related to the Dow merger. Included in the write-down were charges of $292 million for assets and facilities that were rendered redundant as a result of the merger, $81 million for lease abandonment reserves, $138 million for asset impairments, and $94 million for losses on divestitures required for regulatory approval of the merger. Duplicate assets consisted principally of capitalized software costs, information technology equipment and research and development facilities and equipment, all of which were written off duringIn the first quarter of 2001. The fair values2003, certain studies regarding non-strategic or under-performing assets (initiated following the appointment of a new CEO at Dow in late 2002) were completed and management made decisions relative to certain assets. These decisions resulted in the write-down of the impaired assets,net book value of three manufacturing facilities totaling $24 million (the largest of which include production facilities and transportation equipment, were determined based on discounted cash flows and an appraisal, respectively. These components of the special charge will require limited future cash outlays, and will result in a decrease in annual depreciation of approximately $62 million. In November 2001, the decision to close a research and development facility in Bound Brook, New Jersey was reversed, in light of difficult economic conditions; the facility will now remain open until at least 2005. Consequently, $55$16 million of the special charge was reversed during the fourth quarter of 2001. At December 31, 2001, $77 million of the reserve remained for the abandonment of leased facilities and demolition costs; at September 30, 2002, $65 million of the reserve remained. The leased facilities will remain open until at least 2005.

        The following table summarizes the activity in the special charge reserve:

In millions

 Labor-related
Costs

 Transaction
Costs

 Write-down of
Duplicate Assets
and Facilities

 Total
 
2001:             
Special charge $629 $41 $605 $1,275 
Adjustments to reserve  3    (55) (52)
Charges against reserve  (327) (41) (473) (841)
  
 
 
 
 
Balance at Dec. 31, 2001 $305   $77 $382 
  
 
 
 
 
2002:             
Charges against reserve  (57)   (4) (61)
  
 
 
 
 
Balance at March 31, 2002 $248   $73 $321 
  
 
 
 
 
Charges against reserve  (21)   (4) (25)
  
 
 
 
 
Balance at June 30, 2002 $227   $69 $296 
  
 
 
 
 
Adjustments to reserve  13      13 
Charges against reserve  (13)   (4) (17)
Completion of program (1)  (227)   (65) (292)
  
 
 
 
 
Balance at September 30, 2002         
  
 
 
 
 

(1)
Upon completion of the program, the outstanding merger-related reserve for employee-related costs associated with pension and postretirement benefit plans is considered part of the Corporation's regular

9


Note D—Related Party Transactions

        In the second quarter of 2001, the Corporation commenced selling products to Dow to simplify the customer interface process. Products are sold to and purchased from Dow in accordance with the terms of Dow's longstanding intercompany pricing policies. The application of these policies results in products being sold to Dow at market-based prices. The Corporation procures certain commodities and raw materials through a Dow subsidiary and pays a commission to that Dow subsidiary based on the volume and type of commodities and raw materials purchased. The commission expense is included in "Sundry income (expense)—net" in the consolidated statement of income. Purchases from that Dow subsidiary were approximately $289 million during the third quarter of 2002 and $801 million for the first nine months of 2002.

        Subsequent to the merger, the Corporation entered into a master services agreement with Dow whereby Dow provides services, including, but not limited to, accounting, legal, treasury (investments, cash management, risk management, insurance), procurement, human resources, environmental, health and safety, and business management for UCC. Under the master services agreement with Dow, for general administrative and overhead type services that Dow routinely allocates to various businesses, UCC is charged the cost of those services based on the Corporation's and Dow's relative manufacturing conversion costs. This arrangement results in a quarterly charge of approximately $5 million (included in "Sundry income (expense)—net"). For services that Dow routinely charges based on effort, UCC is charged the cost of such services on a fully absorbed basis, which includes direct and indirect costs. Additionally, certain Dow employees are contracted to UCC, and Dow is reimbursed for all direct employment costs of such employees. Management believes the method used for determining expenses charged by Dow is reasonable. Dow provides these services by leveraging its centralized functional service centers to provide services at a favorable cost that management believes provides an advantage to the Corporation.

        As part of Dow's cash management process, UCC is a party to revolving loans with Dow that have LIBOR-based interest rates with varying maturities. The reduction in noncurrent receivables from related companies primarily reflects a $483 million repayment of a note receivable associated with the fundingimpairment and shutdown of the ethylene production facilities in Seadrift, Texas, by year-end 2003) and polyethylene plants in Canada, owned by Dow Chemical Canada Inc.,the impairment of a chemical transport vessel (to be sold in the second quarter of 2002.

        The Corporation declared and paid a dividend2003) of approximately $257 million to its shareholder on April 15, 2002.

        In April 2002, the Corporation sold its ownership interest in a subsidiary in China to a Dow subsidiary also located in China for approximately $20$11 million. Accordingly, the consolidated balance sheet at September 30, 2002 does not include the assets and liabilities of the subsidiary, and the consolidated income statement includes the subsidiary's results of operations from January 1, 2002 through March 31, 2002.

Note E—Goodwill and Other Intangible AssetsNOTE D    INVENTORIES

        The Corporation ceased amortizing goodwill upon adoption of SFAS No. 142 (see Note B) on January 1, 2002. Accumulated amortization for goodwill upon adoption of SFAS No. 142 was $50 million.        The following table provides pro forma results fora breakdown of inventories at March 31, 2003 and December 31, 2002:

Inventories
(in millions)

 Mar. 31,
2003

 Dec. 31,
2002

Finished goods $46 $96
Work in process  32  28
Raw materials  32  24
Supplies  78  71
  
 
Total inventories $188 $219
  
 

        The reserves reducing inventories from the threefirst-in, first-out ("FIFO") basis to the last-in, first-out ("LIFO") basis amounted to $150 million at March 31, 2003 and nine months ended September 30, 2001, compared with actual results for the three and nine months ended September 30, 2002, as if the non-amortization provisions of SFAS No. 142 had been applied in 2001:$81 million at December 31, 2002.

 
 Three months ended
 Nine months ended
 
In millions

 Sept. 30,
2002

 Sept. 30,
2001

 Sept. 30,
2002

 Sept. 30,
2001

 
Reported net income (loss) $33.0 $(12.0)$127.0 $(844.0)
Add back:             
 Goodwill amortization, net of tax    1.6    3.6 
 Equity method goodwill amortization, net of tax    0.6    1.7 
  
 
 
 
 
Adjusted net income (loss) $33.0 $(9.8)$127.0 $(838.7)
  
 
 
 
 

10NOTE E    OTHER INTANGIBLE ASSETS


        The following table provides information regarding the Corporation's other intangible assets:



 At September 30, 2002
 At December 31, 2001

 At March 31, 2003
 At December 31, 2002
In millions

 Gross
Carrying
Amount

 Accumulated
Amortization

 Net
 Gross
Carrying
Amount

 Accumulated
Amortization

 Net
(in millions)

(in millions)

 Gross
Carrying
Amount

 Accumulated
Amortization

 Net
 Gross
Carrying
Amount

 Accumulated
Amortization

 Net
Intangible assets with finite lives:Intangible assets with finite lives:                  Intangible assets with finite lives:                  
Licenses and intellectual property $36 $(26)$10 $35 $(24)$11Licenses and intellectual property $36 $(29)$7 $36 $(28)$8
Patents  5  (3) 2  5  (2) 3Patents  5  (3) 2  5  (3) 2
Software  179  (166) 13  178  (164) 14Software  94  (82) 12  95  (82) 13
Other  1  (1)   1  (1) Other  2  (1) 1  1  (1) 
 
 
 
 
 
 
 
 
 
 
 
 
Total $221 $(196)$25 $219 $(191)$28Total $137 $(115)$22 $137 $(114)$23
 
 
 
 
 
 
 
 
 
 
 
 

        Amortization expense for other intangible assets (not including software) was $1 million in the thirdfirst quarter of 2002,2003, compared with $0.5$1 million for the same period last year. Year to date, amortization expense for other intangible assets (not including software) was $3 million, compared with $4.5 million for the nine months ended September 30, 2001. Amortization expense for

9



software, which is included in cost of sales, totaled $1 million in the third quarterfirst quarters of 2002both 2003 and 2001. Year to date, amortization expense for software was $3 million in 2002 and 2001.2002. Total estimated amortization expense for 2002 and the next five succeeding fiscal years is as follows:

In millions

 Estimated
Amortization
Expense

2002 $7.5
(in millions)

 Estimated
Amortization
Expense

2003 7.6 $5.6
2004 7.5 5.5
2005 4.4 2.3
2006 1.6 2.0
2007 0.3 1.8
 
2008 1.8

Note F—Commitments and Contingent LiabilitiesNOTE F    COMMITMENTS AND CONTINGENT LIABILITIES

Environmental

        Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. The Corporation had accrued obligations of $132$130 million at September 30,December 31, 2002 for environmental matters,remediation and restoration costs, including $30$35 million for the remediation of Superfund sites. At March 31, 2003, the Corporation had accrued obligations of $125 million for environmental remediation and restoration costs, including $34 million for the remediation of Superfund sites. This is management's best estimate of the costs for remediation and restoration with respect to environmental matters for which the Corporation has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to twice that amount. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and evolving technologies for handling site remediation and restoration. It is the opinion of the Corporation's management that the possibility is remote that costs in excess of those accrued or disclosed will have a material adverse impact on the Corporation's consolidated financial statements.

Litigation

        The Corporation and its subsidiaries are involved in a number of legal proceedings and claims with both private and governmental parties. These cover a wide range of matters, including, but not limited to: product liability; trade regulation; governmental regulatory proceedings; health, safety and environmental matters; employment; patents; contracts; taxes; and commercial disputes. In some of these legal proceedings and claims, the cost of remedies that may be sought or damages claimed is substantial.

        Separately, the Corporation is and has been involved in a large number of asbestos-related suits filed for the most part,primarily in various state courts at various times overduring the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both generalactual and punitive damages, often in very large amounts. The alleged claims primarily relate to products that UCC sold in the past;past, alleged

11



exposure to asbestos-containing products located on UCC's premises;premises, and UCC's responsibility for asbestos suits filed against a divested subsidiary—former subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to the Corporation's products.

        The rate at which plaintiffs filed asbestos-related suits against various companies, including the Corporation and Amchem, increased in both 2001 and 2002, influenced by the bankruptcy filings of

10



numerous defendants in asbestos-related litigation. The Corporation expects more asbestos-related suits to be filed against it and Amchem in the future. The Corporation will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

        Typically, the Corporation is only one of many named defendants, many of which, including UCC and Amchem, were members of the Center for Claims Resolution ("CCR") which sought to resolve, an entity that defended and resolved asbestos cases on behalf of its members. As members of the CCR, the Corporation's and Amchem's strategy was to resolve the claims against them at the relatively small percentage allocated to them pursuant to the CCR's collective defense. The CCR ceased operating in this manner in February 2001, although it still administersexcept to administer certain settlements. The Corporation then began utilizingusing Peterson Asbestos Claims Enterprise, but only for claims processing and insurance invoicing.

        The rate at which plaintiffs file asbestos-related suits againstCorporation is a wholly owned subsidiary of Dow, and certain members of Dow's legal department and certain Dow management personnel have been retained to provide their experience in mass tort litigation to assist the Corporation and Amchem has been influenced byin responding to asbestos-related matters. In early 2002, the bankruptcy filingsCorporation hired new outside counsel to serve as national trial counsel. In connection with these actions, aggressive defense strategies were designed to reduce the cost of numerous defendants inresolving all asbestos-related litigationclaims, including several former CCR members. Thethe elimination of claims that lack demonstrated illness or causality.

        At the end of 2001 through the third quarter of 2002, the Corporation expects morehad concluded it was not possible to estimate its cost of disposing of asbestos-related suits toclaims that might be filed against it and Amchem in the future. At this time,future due to a number of reasons, including its lack of sufficient comparable loss history from which to assess either the number or value of future asbestos-related claims. During the third and fourth quarters of 2002, the Corporation cannotworked with Analysis, Research & Planning Corporation ("ARPC"), a consulting firm with broad experience in estimating resolution costs associated with mass tort litigation, including asbestos, to explore whether it would be possible to estimate the cost of disposing of pending and future asbestos-related claims that have been, and could reasonably be expected to be, filed against the Corporation and Amchem.

        The Corporation provided ARPC with all relevant data regarding asbestos-related claims filed against UCC and Amchem through November 6, 2002. ARPC concluded that it was not possible to estimate the full range of the cost of resolving future asbestos-related claims against UCC and Amchem, because of various uncertainties associated with the litigation of those claims. These uncertainties, which hindered the Corporation's ability to project future claim volumes and resolution costs, included the following:

        Despite its inability to estimate the full range of the cost of resolving future asbestos-related claims, ARPC advised the Corporation that it would be possible to determine an estimate of a reasonable forecast of the cost of resolving pending and future asbestos-related claims likely to face the Corporation and Amchem, if certain assumptions were made. Specifically, ARPC advised the

11



Corporation that for purposes of determining an estimate it is reasonable to assume that in the near term asbestos-related claims filed against UCC and Amchem are unlikely to return to levels below those experienced prior to 2001—when the recent spike in filings commenced—and that average claim values are unlikely to return to levels below those experienced in 2001-2002, the years immediately following CCR's cessation of operations. ARPC advised the Corporation that, by assuming that future filings were unlikely to exceed the levels experienced prior to 2001 and extrapolating from 2001 and 2002 average claim values, ARPC could make a reasonable forecast of the cost of resolving asbestos-related claims facing UCC and Amchem. ARPC also advised that forecasts of resolution costs for a 10 to 15 year period from the date of the forecast are likely to be more accurate than forecasts for longer periods of time.

        In projecting the resolution costs for future asbestos-related claims, ARPC applied two methodologies that have been widely used for forecasting purposes. Applying these methodologies, ARPC forecast the number and allocation by disease category of those potential future claims on a year-by-year basis through 2049. ARPC then calculated the percentage of claims in each disease category that had been closed with payments in 2001 and 2002. Using those percentages, ARPC calculated the number of future claims by disease category that would likely require payment by UCC and Amchem and multiplied the number of such claims by the mean values paid by UCC and Amchem, respectively, to dispose of such claims in 2001 and 2002. In estimating the cost of resolving pending claims, ARPC used a process similar to that used for calculating the cost of resolving future claims.

        As of December 31, 2002, ARPC estimated the undiscounted cost of resolving pending and future asbestos-related claims against UCC and Amchem, excluding future defense and processing costs, for the 15-year period from the present through 2017 to be between approximately $2.2 billion and $2.4 billion, depending on which of the two accepted methodologies was used.

        Although ARPC provided estimates for a longer period of time, based on ARPC's advice that forecasts for shorter periods of time are more accurate and in light of the uncertainties inherent in making long-term projections, the Corporation determined that the 15-year period through 2017 is the reasonable time period for projecting the cost of disposing of its future asbestos-related claims. The Corporation will aggressively defend or reasonably resolve, as appropriate, bothconcluded that it is probable that the undiscounted cost of disposing of its asbestos-related pending and future cases. To date, substantially all ofclaims ranges from $2.2 billion to $2.4 billion, which is the amounts paidrange for the 15-year period ending in 2017 as estimated by ARPC using both methodologies. Accordingly, the Corporation increased its asbestos-related liability for pending and future claims at December 31, 2002 to resolve$2.2 billion, excluding future defense and processing costs. At March 31, 2003, the asbestos-related suits are covered by third-party insurance.liability for pending and future claims was $2.1 billion.

        For pending claims,The Corporation also increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion at December 31, 2002, substantially exhausting its asbestos product liability coverage. This resulted in a net income statement impact of $828 million, $522 million on an after-tax basis, in the fourth quarter of 2002. At March 31, 2003, the receivable for insurance recoveries related to the Corporation's asbestos liability was $1.3 billion. The insurance receivable related to the asbestos liability was determined after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which the Corporation and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. In addition, the Corporation had asbestos-related litigation accrualsreceivables for insurance recoveries for defense and resolution costs of $233 million and related insurance recovery receivables of $223$219 million at December 31, 2001. At September 30, 2002 and $249 million at March 31, 2003.

        The amounts recorded for the Corporation had asbestos-related litigation accruals of $362 millionliability and related insurance recovery receivablesreceivable described above were based upon currently known facts. However, projecting future events, such as the number of $344 million. In addition, at September 30, 2002,new claims to be filed each year, the average cost of disposing of each such claim, coverage issues

12



among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries to be higher or lower than those projected or those recorded. The Corporation expenses defense and processing costs as incurred. Accordingly, defense and processing costs incurred in the future for asbestos-related litigation, net of insurance, will impact results of operations in future periods.

        Because of the uncertainties described above, management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing the Corporation had other litigation accruals, unrelated to environmental or asbestos litigation,and Amchem. Management believes that it is reasonably possible that the cost of $25 milliondisposing of the Corporation's asbestos-related claims, including future defense and related insurance recovery receivablesprocessing costs, could have a material adverse impact on the results of $25 million.operations and cash flows for a particular period and on the consolidated financial position of the Corporation.

        While it is not possible at this time to determine with certainty the ultimate outcome of any of the legal proceedings and claims referred to in this filing, management believes that adequate provisions have been made for probable losses with respect to pending claims and proceedings, and that, except for the asbestos-related matters described above, the ultimate outcome of all known and future claims, after provisions for insurance, will not have a material adverse effectimpact on the results of operations, cash flows and consolidated financial position of the Corporation, but could have a material effect on the consolidated results of operations in a given quarter or year.Corporation. Should any losses be sustained in connection with any of such legal proceedings and claims in excess of provisions provided and available insurance, they will be charged to income when determinable.

Purchase Commitments

        The Corporation has purchase agreements, including one major agreement in 2002 and 2001 (two in 2000), for the purchase of ethylene-related products in the United States. Total purchases under these agreements were $62 million in 2002, $63 million in 2001 and $171 million in 2000. The fixed and determinable portion of obligations under these purchase commitments at December 31, 20012002 are presented in the following table:

Fixed and Determinable Portion of Take or Pay and
Throughput Obligations at December 31, 2001 (in millions)

  
2002 $17
Fixed and Determinable Portion of Take or Pay and
Throughput Obligations at December 31, 2002
(in millions)

  
2003 17 $14.9
2004 6 5.3
2005 through expiration of contracts 
2005 0.3
2006 through expiration of contracts 0.3
 
 
Total $40 $20.8
 
 

Guarantees

        The Corporation provides a variety of guarantees, which are described more fully below.

OtherGuarantees

        The Corporation had additional contingenthas undertaken obligations relating primarily to guarantee the performance agreementsof a nonconsolidated affiliate and a former subsidiary of the Corporation (via delivery of cash or other assets) if specified triggering events occur. Non-performance under a contract for commercial obligations by the guaranteed party triggers the obligation of the Corporation.

13



Residual Value Guarantees

        The Corporation provides a guarantee related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

        The following tables provide a summary of the aggregate terms, maximum future payments, and associated liability reflected in the consolidated balance sheet for each type of guarantee.

Guarantees at March 31, 2003
(in millions)

 Final
Expiration

 Maximum Future
Payments

 Recorded
Liability

Guarantees 2007 $16 
Residual Value Guarantees 2005  82 
    
 
Total   $98 
    
 
Guarantees at December 31, 2002
(in millions)

 Final
Expiration

 Maximum Future
Payments

 Recorded
Liability

Guarantees 2007 $17 
Residual Value Guarantees 2005  82 
    
 
Total   $99 
    
 

NOTE G    VARIABLE INTEREST ENTITIES

        UCC has an operating lease with a special purpose entity that qualifies as a variable interest entity ("VIE") under FIN No. 46, "Consolidation of Variable Interest Entities." Based on the current terms of the lease agreement and the residual value guarantee UCC provides to the lessor, the Corporation expects to be the primary beneficiary of the VIE. As a result, if the facts and circumstances remain the same, UCC will be required to consolidate the assets and liabilities held by the VIE in the third quarter of 2003.

        The VIE, established in 2000, is a U.S. trust that leases railcars to UCC for use in the United States. The lease expires in 2005. The value of the leased railcars and corresponding approximate amount of debt of the VIE was $100 million at March 31, 2003 and December 31, 2002. The Corporation has not determined the carrying amount of the assets that will be included in the consolidated balance sheet upon consolidation of the VIE. Accordingly, the Corporation has not determined the cumulative effect adjustment that will be required upon adoption of FIN No. 46.

        Upon termination or expiration of the lease, UCC may return the assets to the lessor, renew the lease, or purchase the assets for an amount based on a fair market value determination. UCC has provided a residual value guarantee of $82 million at March 31, 2003 and December 31, 2002 to the lessor. Given the productive nature of the assets, it is probable they will have continuing value to UCC or another company in excess of the residual value guarantees.

NOTE H    RELATED PARTY TRANSACTIONS

        The Corporation sells products to Dow to simplify the customer interface process. Products are sold to and purchased from Dow in accordance with the terms of Dow's longstanding intercompany pricing policies. The application of these policies results in products being sold to and purchased from Dow at market-based prices. The Corporation also procures certain commodities and raw materials through a Dow subsidiary and pays a commission to that Dow subsidiary based on the volume and type of commodities and raw materials purchased. The commission expense is included in "Sundry income (expense)—net" in the consolidated statements of operations. Purchases from that Dow subsidiary were approximately $489 million during the first quarter of 2003 and $236 million during the first quarter of 2002.

14



        The Corporation has a master services agreement with Dow whereby Dow provides services, including, but not limited to, accounting, legal, treasury (investments, cash management, risk management, insurance), procurement, human resources, environmental, health and safety, and business management for UCC. Under the master services agreement with Dow, for general administrative and overhead type services that Dow routinely allocates to various businesses, UCC is charged the cost of those services based on the Corporation's and Dow's relative manufacturing conversion costs. This arrangement results in a quarterly charge of approximately $5 million (included in "Sundry income (expense)—net").

        For services that Dow routinely charges based on effort, UCC is charged the cost of such services on a fully absorbed basis, which includes direct and indirect costs. Additionally, certain Dow employees are contracted to UCC and Dow is reimbursed for all direct employment costs of such employees. Management believes the method used for determining expenses charged by Dow is reasonable. Dow provides these services by leveraging its centralized functional service centers to provide services at a cost that management believes provides an advantage to the Corporation.

        The monitoring and execution of risk management policies related to interest rate, foreign currency and equity price risks, which are based on Dow's risk management philosophy, are provided as a service to UCC.

        As part of Dow's cash management process, UCC is a party to revolving loans with Dow that have LIBOR-based interest rates with varying maturities. On March 24, 2003, the revolving loan agreement with Dow that allowed the Corporation to borrow up to $1.5 billion was terminated and replaced on March 25, 2003 with a one-year note payable of approximately $65 million for the outstanding balance on the terminated revolving loan agreement, and a new revolving loan agreement with Dow that allows the Corporation to borrow up to $1.0 billion. The new revolving loan agreement is secured, pursuant to a collateral agreement, by various assets, including UCC's deposit accounts, intercompany obligations, and equity interests in various subsidiaries and joint ventures. The maturity date of the new revolving loan agreement is March 25, 2004; however, Dow may demand repayment with 30 days written notice to the Corporation.

        In April 2002, the Corporation sold its ownership interest in a subsidiary in China to a Dow subsidiary also located in China for approximately $20 million. Accordingly, the consolidated balance sheet at December 31, 2001 totaling $173 million, of which $19 million related to guarantees of debt.

12



Note G—Inventories

        The following table provides a breakdown of inventories at September 30, 2002 does not include the assets and December 31, 2001:

Inventories
In millions

 Sept. 30,
2002

 Dec. 31,
2001

Finished goods $220 $230
Work in process  34  33
Raw materials  38  38
Supplies  70  62
  
 
Total inventories $362 $363
  
 

        The reserves required to adjust inventories from the first-in, first-out ("FIFO") basis to the last-in, first-out ("LIFO") basis amounted to a decrease of $113 million at September 30, 2002, and a decrease of $198 million at December 31, 2001.

        During the quarter ended June 30, 2001, certain inventory quantities were reduced which resulted in a liquidation of certain LIFO inventory layers carried at lower costs which prevailed in prior years. The effectliabilities of the liquidation was to decrease costsubsidiary, and the consolidated statements of goods sold by $51 million and increase after-tax earnings by $33 million.operations include the subsidiary's results of operations from January 1, 2002 through March 31, 2002.



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

        Pursuant to General Instruction H of Form 10-Q "Omission of Information by Certain Wholly-Owned Subsidiaries",Subsidiaries," this section includes only management's narrative analysis of the results of operations for the three and nine month periodsperiod ended September 30, 2002,March 31, 2003, the most recent periods,period, compared with the three and nine month periodsperiod ended September 30, 2001,March 31, 2002, the corresponding periodsperiod in the preceding fiscal year.

        References below to "Dow" refer to The Dow Chemical Company and its consolidated subsidiaries.

Disclosure Regarding Forward-Looking InformationDISCLOSURE REGARDING FORWARD-LOOKING INFORMATION

        The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of Union Carbide Corporation (the "Corporation" or "UCC"). This section covers the current performance and outlook of the Corporation. The forward-looking statements contained in this section and in other parts of this document involve risks and uncertainties that may affect the Corporation's operations, markets, products, services, prices and other factors as more fully discussed elsewhere and in filings with the U.S. Securities and Exchange Commission ("SEC")(SEC). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Corporation's expectations will be realized. The Corporation assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Results of OperationsRESULTS OF OPERATIONS

        The Corporation reported net income of $33 million for the third quarter of 2002, compared with a net loss of $12$59 million for the samefirst quarter of 2001. Year to date2003 compared with net income for 2002 was $127 million, compared with a net loss of $844$37 million for 2001.the first quarter of 2002. The year to date results for 2001the first quarter of 2003 were negatively impacted by a special chargesignificantly higher hydrocarbon feedstocks and energy costs, in addition to asset write-downs and impairments of $1,262$35 million ($829 million after tax) related to the Dow merger (see Note C to the Consolidated Financial Statements). The Corporation recorded an additional special charge of $13 million for employee severancerestructuring activities in the thirdfirst quarter of 2002.2003.

        Total net sales for the first quarter of $1,1792003 were $1,289 million compared with $1,119 million for the thirdfirst quarter of 2002. Selling prices to Dow are based on market prices for the related products. Increases in average selling prices occurred for most products in the first quarter of 2003 compared with the first quarter of 2002, were flat compared with $1,177 millionled by polyethylene and ethylene glycol ("EG"), the Corporation's principal products. The Corporation also reported substantial volume gains for the third quarter last year. Year to date, total net sales decreased 22 percent to $3,444 million from $4,409 million for 2001. Year to date results were impacted by a decline in selling prices which more than offset increased volumes. The decline in net sales this year was also partially attributable to the absence of sales from former wholly owned entities in Europe, Latin AmericaEG, vinyl acetate monomer, and Canada that were contributed to wholly owned subsidiaries of Dow on various dates in 2001 in exchange for ownership interests in those subsidiaries. Since the second quarter of 2001, sales to Dow have been replacing trade sales in order to simplify the customer interface process.oxo products.

        Cost of sales declined $78increased $301 million (7(30 percent) in the thirdfirst quarter of 2003 compared with the first quarter of 2002, compared withdue primarily to a $250 million increase in hydrocarbon feedstock and energy costs, reflecting a 65 percent increase in costs of these raw materials over the thirdfirst quarter last year, primarily dueof 2002. In addition, asset write-downs and impairments of $24 million related to merger synergies. As a result, gross margin for the quarter improved to 12.1 percent from 5.3 percent last year. Year to daterestructuring activities were included in cost of sales for the first quarter of 2003. Gross margin declined $1,080 million (26 percent) in 2002 compared with last year, which is consistent with the related decreasefirst quarter of 2003, as the substantial increase in sales for 2002, as well as decreases due to merger synergies.raw material costs were not entirely recovered by the higher selling prices.

        Research and development expenses declined $6$7 million in the thirdfirst quarter of 20022003 compared with the same quarter last year and declined $24 million for the first three quarters of 2002 compared with the first three quarters of 2001.year. Selling, general and administrative expenses declined $21$4 million in the thirdfirst quarter of 20022003 compared with the same quarter last year and declined $101 million for the first nine months of 2002 compared with the first nine months of 2001.year. These declines are attributable to the realizationcost containment efforts begun in late 2002, as well as the impact of cost synergies associated with the merger.workforce reductions that occurred during 2002.

        Equity in earnings of nonconsolidated affiliates decreased slightly from $19increased to $10 million in the thirdfirst quarter of 2001 to $172003 from $3 million in the thirdfirst quarter of 2002. Year to date, equity earnings decreased $23 million compared with the first three quarters of 2001. The decline in year to date 2002, results is primarily due to lower earnings in 2002 compared to 2001 fromreflecting a strong performance by EQUATE Petrochemical

16



Company K.S.C., a Kuwait-based joint venture, and UOP LLC,that was partially offset by increased losses at the Corporation's joint ventures in Malaysia due to a joint venture with Honeywell that recorded a restructuring charge in the second quarter of 2002, as well as the absence of earnings from two former equity companies in Canada (Alberta & Orient Glycol Company Limited and Petromont and Company, Limited Partnership) owned by Dow Chemical Canada Inc. since October 1, 2001.scheduled plant turnaround.

14



        Sundry income (expense)—net includes a variety of income and expense items such as the gain or loss on foreign currency exchange, dividends from investments, commissions, charges for management services provided by Dow, and gains and losses on sales of investments and assets. Sundry income (expense)—net for the thirdfirst quarter of 20022003 was expense of $16$15 million, compared with incomeexpense of $7$3 million for the thirdfirst quarter last year. Results for the thirdfirst quarter of 20012003 included a gainexpense of $11 million fromassociated with the saleimpairment of certain available for sale securities and assets. Yeara chemical transport vessel to date, sundry income (expense)—net was incomebe sold in the second quarter of $14 million compared with income of $31 million last year. The year to date 2001 results included a gain of $23 million from the sale of investments.2003.

        Interest income for the thirdfirst quarter of 2002 increased slightly2003 declined to $4$2 million from $3$15 million in the thirdfirst quarter of last year. Interest income for the first three quarters of 2002 increased to $31 million from $7 million in the first three quartersquarter of last year. The year2002 included $9 million related to date increase is primarily due to interest earned on the noncurrenta $483 million related company note receivable from related companies whichthat was repaid in the second quarter of 2002.

Interest expense and amortization of debt discount for the thirdfirst quarter of 20022003 was $33$34 million compared with $45$33 million in the thirdfirst quarter of last year. Year to date, interest expense and amortization of debt discount decreased to $99 million from $143 million in 2001. This reduction is consistent with the lower debt levels at September 30, 2002 compared with September 30, 2001.

        The effective tax rate for the thirdfirst quarter of 20022003 was 49.235.8 percent compared with 42.119.6 percent for the same quarter last year. Year to date, theThe effective tax rate was 38.7 percent versus 36.2 percent last year.fluctuates based on, among other factors, where income is earned and the level of income relative to tax credits available.

Asbestos-Related Matters

        The Corporation is and its subsidiaries are involved in a number of legal proceedings and claims with both private and governmental parties. These cover a wide range of matters, including, but not limited to: product liability; trade regulation; governmental regulatory proceedings; health, safety and environmental matters; employment; patents; contracts; taxes; and commercial disputes. In some of these legal proceedings and claims, the cost of remedies that may be sought or damages claimed is substantial.

        Separately, the Corporation ishas been involved in a large number of asbestos-related suits filed for the most part,primarily in various state courts at various times overduring the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both generalactual and punitive damages, often in very large amounts. The alleged claims primarily relate to products that UCC sold in the past;past, alleged exposure to asbestos-containing products located on UCC's premises;premises, and UCC's responsibility for asbestos suits filed against a divested subsidiary—former subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to the Corporation's products.

        The rate at which plaintiffs filed asbestos-related suits against various companies, including the Corporation and Amchem, increased in both 2001 and 2002, influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation. The Corporation expects more asbestos-related suits to be filed against it and Amchem in the future. The Corporation will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

        Typically, the Corporation is only one of many named defendants, many of which, including UCC and Amchem, were members of the Center for Claims Resolution ("CCR") which sought to resolve, an entity that defended and resolved asbestos cases on behalf of its members. As members of the CCR, the Corporation's and Amchem's strategy was to settleresolve the claims as twoagainst them at the relatively small (percentage wise) members ofpercentage allocated to them pursuant to the CCR group.CCR's collective defense. The CCR ceased operating in this manner in February 2001, although it still administersexcept to administer certain settlements. The Corporation then began utilizingusing Peterson Asbestos Claims Enterprise, but only for claims processing and insurance invoicing.

        The rate at which plaintiffs file asbestos-related suits against the Corporation is a wholly owned subsidiary of Dow, and Amchem has been influenced by the bankruptcy filingscertain members of numerous defendants in asbestos-related litigation including several former CCR members. Cases filed against the CorporationDow's legal department and Amchem contain a large percentage of claims that do not allege a particular injury ("Non-Specific Claims").

certain Dow now owns 100 percent of the stock of the Corporation and hasmanagement personnel have been retained to provide itstheir experience in mass tort litigation to manageassist the Corporation's responseCorporation in responding to asbestos-related liability. Thematters. In early 2002, the Corporation has hired new outside counsel to serve as national trial counselcounsel. In connection with these actions, aggressive defense strategies were designed to aggressively defendreduce the cost of resolving all asbestos-related claims, including the elimination of claims that lack demonstrated illness or reasonably resolve, as appropriate, both pending and future cases. Thecausality.

        At the end of 2001 through the third quarter of 2002, the Corporation expects morehad concluded it was not possible to estimate its cost of disposing of asbestos-related suits toclaims that might be filed against it and

17



Amchem in the future. At this time, the Corporation cannot estimate the liability that will result from future claims. Asdue to a consequencenumber of allreasons, including its lack of the above-stated facts, the Corporation lacks sufficient comparable loss history from which to assess either the number of or the value of future asbestos-related claims. To date, substantiallyDuring the third and fourth quarters of 2002, the Corporation worked with Analysis, Research & Planning Corporation ("ARPC"), a consulting firm with broad experience in estimating resolution costs associated with mass tort litigation, including asbestos, to explore whether it would be possible to estimate the cost of disposing of pending and future asbestos-related claims that have been, and could reasonably be expected to be, filed against the Corporation and Amchem.

        The Corporation provided ARPC with all relevant data regarding asbestos-related claims filed against UCC and Amchem through November 6, 2002. ARPC concluded that it was not possible to estimate the full range of the amountscost of resolving future asbestos-related claims against UCC and Amchem, because of various uncertainties associated with the litigation of those claims. These uncertainties, which hindered the Corporation's ability to project future claim volumes and resolution costs, included the following:

        Despite its inability to estimate the full range of the cost of resolving future asbestos-related claims, ARPC advised the Corporation that it would be possible to determine an estimate of a reasonable forecast of the cost of resolving pending and future asbestos-related claims likely to face the Corporation and Amchem, if certain assumptions were made. Specifically, ARPC advised the Corporation that for purposes of determining an estimate it is reasonable to assume that in the near term asbestos-related claims filed against UCC and Amchem are unlikely to return to levels below those experienced prior to 2001—when the recent spike in filings commenced—and that average claim values are unlikely to return to levels below those experienced in 2001-2002, the years immediately following CCR's cessation of operations. ARPC advised the Corporation that, by assuming that future filings were unlikely to exceed the levels experienced prior to 2001 and extrapolating from 2001 and 2002 average claim values, ARPC could make a reasonable forecast of the cost of resolving asbestos-related claims facing UCC and Amchem. ARPC also advised that forecasts of resolution costs for a 10 to 15 year period from the date of the forecast are likely to be more accurate than forecasts for longer periods of time.

        In projecting the resolution costs for future asbestos-related claims, ARPC applied two methodologies that have been widely used for forecasting purposes. Applying these methodologies, ARPC forecast the number and allocation by disease category of those potential future claims on a year-by-year basis through 2049. ARPC then calculated the percentage of claims in each disease category that had been closed with payments in 2001 and 2002. Using those percentages, ARPC calculated the number of future claims by disease category that would likely require payment by UCC and Amchem and multiplied the number of such claims by the mean values paid by UCC and Amchem, respectively, to dispose of such claims in 2001 and 2002. In estimating the cost of resolving

18



pending claims, ARPC used a process similar to that used for calculating the cost of resolving future claims.

        As of December 31, 2002, ARPC estimated the undiscounted cost of resolving pending and future asbestos-related claims against UCC and Amchem, excluding future defense and processing costs, for the 15-year period from the present through 2017 to be between approximately $2.2 billion and $2.4 billion, depending on which of the two accepted methodologies was used.

        Although ARPC provided estimates for a longer period of time, based on ARPC's advice that forecasts for shorter periods of time are more accurate and in light of the uncertainties inherent in making long-term projections, the Corporation determined that the 15-year period through 2017 is the reasonable time period for projecting the cost of disposing of its future asbestos-related claims. The Corporation concluded that it is probable that the undiscounted cost of disposing of its asbestos-related pending and future claims ranges from $2.2 billion to resolve asbestos-related suits are covered$2.4 billion, which is the range for the 15-year period ending in 2017 as estimated by third-party insurance.

        For pending claims,ARPC using both methodologies. Accordingly, the Corporation hadincreased its asbestos-related litigation accruals of $233 millionliability for pending and future claims at December 31, 20012002 to $2.2 billion, excluding future defense and processing costs. At March 31, 2003, the asbestos-related liability for pending and future claims was $2.1 billion.

        The Corporation also increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion at December 31, 2002, substantially exhausting its asbestos product liability coverage. This resulted in a net income statement impact of $828 million, $522 million on an after-tax basis, in the fourth quarter of 2002. At March 31, 2003, the receivable for insurance recovery receivables of $223 million. At September 30, 2002,recoveries related to the Corporation had asbestos-related litigation accruals of $362 million and related insurance recovery receivables of $344 million. The litigation accruals were determined by considering the number of claims pending against the Corporation and

15



Amchem, taking into account claims administration records indicating the severity of the alleged injury. Because many of the pending claims are Non-Specific Claims, the Corporation has calculated several probable liability outcomes based on estimates and historic distributions of personal injury claim types and settlement and resolution amounts. The liability estimates at September 30, 2002 ranged from a low of $351 million to a high of $455 million. Upon review by management, it was determined that the most reasonable estimate was $362 million, which is within the estimable range. The Corporation's asbestos litigation accrual at September 30, 2002 reflected all claims for which the Corporation had received notification through the end of the third quarter of 2002, and the use of average resolution values to calculate probable outcomes. The accrual also included settled claims that had not yet been paid. The number of claims filed in the third quarter of 2002 remained relatively consistent with the number of claims filed in the first and second quarters of 2002, but below the high level of claims filed in the middle of last year.

liability was $1.3 billion. The insurance receivables for asbestos-relatedreceivable related to the asbestos liability werewas determined after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which the Corporation and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The insurance receivable associated with the most reasonable probable liability outcome for pending claims is $344 million and has been recorded at September 30, 2002. This resulted in a net income statement impact toIn addition, the Corporation had receivables for insurance recoveries for defense and resolution costs of $5.0$219 million for asbestos-related expense in the third quarter ofat December 31, 2002 bringing the year to date impact to $8.5 million. In all of the probable outcomes for pending claims, sufficient insurance coverage exists to provide a similar percentage of coverage for the accrued liability. If the maximum probable outcome for pending claims of $455and $249 million were in fact to materialize, the impact would be an additional charge of $15 million to income, which is not material to the consolidated financial statements. In addition, insurance is available for future claims.at March 31, 2003.

        The amounts recorded for the litigation accrualasbestos-related liability and related insurance receivable aredescribed above were based upon currently known facts. IfHowever, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of each such claim, coverage issues among insurers, and the costcontinuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries to resolve such claims differ frombe higher or lower than those projected or those recorded. The Corporation expenses defense and processing costs as incurred. Accordingly, defense and processing costs incurred in the current assumptions used by managementfuture for asbestos-related litigation, net of insurance, will impact results of operations in arriving at its estimates for the recorded amounts, this may impact management's future assessmentsperiods.

        Because of the ultimate outcomeuncertainties described above, management cannot estimate the full range of the cost of resolving pending and future asbestos-related legal proceedings.

        Whileclaims facing the Corporation and Amchem. Management believes that it is notreasonably possible at this time to determine with certaintythat the ultimate outcomecost of anydisposing of the legal proceedingsCorporation's asbestos-related claims, including future defense and claims referred to in this filing, management believes that adequate provisions have been made for probable losses with respect to pending claims and proceedings, and that the ultimate outcome of all known and future claims, after provisions for insurance, will notprocessing costs, could have a material adverse effectimpact on the results of operations and cash flows for a particular period and on the consolidated financial position of the Corporation, but could have a material effect on the consolidated results of operations in a given quarter or year. Should any losses be sustained in connection with any of such legal proceedings and claims in excess of provisions provided and available insurance, they will be charged to income when determinable.Corporation.

OTHER MATTERS

Accounting Changes

        See Note B to the Consolidated Financial Statements for a discussion of accounting changes.changes and recently issued accounting pronouncements.

19



Critical Accounting Policies

        The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make judgments, assumptions and estimates that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Note A to the Consolidated Financial Statements in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2001,2002, describes the significant accounting policies and methods used in the preparation of the Consolidated Financial Statements. Following are some of the Corporation's critical accounting policies impacted by judgments, assumptions and estimates.estimates:

The Corporation is subject to legal proceedings and claims arising out of the normal course of business. The Corporation routinely assesses the likelihood of any adverse judgments or outcomes to these matters, as well as ranges of probable losses. A determination of the amount of the reserves required, if any, for these contingencies is made after thoughtful analysis of each known issue and an analysis of historical claims

16


17



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

        Omitted pursuant to General Instruction H of Form 10-Q.

22




ITEM 4. CONTROLS AND PROCEDURES

        Within the 90 days prior to the date of filing this Quarterly Report on Form 10-Q, the Corporation carried out an evaluation, under the supervision and with the participation of the Corporation's Disclosure Committee and the Corporation's management, including the President (Chief Executive Officer) and the Treasurer (Chief Financial Officer), of the effectiveness of the design and operation of the Corporation's disclosure controls and procedures pursuant to Exchange Act Rule 15d-14. Based upon that evaluation, the President (Chief Executive Officer) and the Treasurer (Chief Financial Officer) concluded that the Corporation's disclosure controls and procedures are effective in timely alerting them to material information relating to the Corporation (including its consolidated subsidiaries) required to be included in the Corporation's periodic SEC filings. Subsequent to the date of that evaluation, there have been no significant changes in the Corporation's internal controls or in other factors that could significantly affect internal controls, nor were any corrective actions required with regard to significant deficiencies and material weaknesses.

18



PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

        No material developments in any legal proceedings, including asbestos-related matters, occurred during the thirdfirst quarter of 2002.2003. For a summary of the history and current status of legal proceedings, including asbestos-related matters, see Management's Discussion and Analysis of Financial Condition and Results of Operations, Asbestos-Related Matters; and Note F to the Consolidated Financial Statements.

Environmental Matters

        On September 27, 2002, the United States Environmental Protection Agency, Region 6 (the "EPA"), filed an administrative complaint against the Corporation charging civil fines of $185,458 for certain alleged violations of the Clean Air Act and the Resource Conservation and Recovery Act at its Texas City Operations. The EPA has proposed to settle these civil fines for $129,818 plus an additional civil fine of $130,753 for other alleged Clean Air Act violations at Texas City Operations that were voluntarily disclosed by the Corporation.


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

Exhibit No.

 Exhibit Description

10.2310.28

 

Amended and Restated ServiceRevolving Credit Agreement, effectivedated as of July 1, 2002,March 25, 2003, between the Corporation and The Dow Chemical Company.

10.23.110.29

 

Service Addendum No. 1 to the ServicePledge and Security Agreement, effectivedated as of February 6, 2001,March 25, 2003, between the Corporation and Thethe Dow Chemical Company.

10.23.223

 

Service Addendum No. 2 to the Service Agreement, effective as of August 1, 2001, between the Corporation and The Dow Chemical Company.

10.24


Amended and Restated Sales Promotion Agreement, effective as of September 13, 2002, between the Corporation and The Dow Chemical Company.

10.25


Agreement (to Provide Materials and Services), effective as of February 6, 2001, between the Corporation and Dow Hydrocarbons and Resources Inc.

10.25.1


Amendment to Agreement (to Provide Materials and Services), effective as of January 1, 2002.

10.26


Revolving Loan Agreement, effective as of February 6, 2001, between the Corporation and The Dow Chemical Company.

10.26.1


Revolving Loan Amendment No. 1, effective as of July 1, 2002, between the Corporation and The Dow Chemical Company.Analysis, Research & Planning Corporation's Consent.

99.1

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.2002.

99.2

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.2002.

23



SIGNATUREUnion Carbide Corporation and Subsidiaries
Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNION CARBIDE CORPORATION
Registrant
 UNION CARBIDE CORPORATION
                        Registrant

Date: October 30, 2002

May 2, 2003

 

 

 


 

By:

 

/s/  
FRANK H. BROD      
Frank H. Brod,
Vice President and Controller
The Dow Chemical Company
Authorized Representative of
Union Carbide Corporation







By:


/s/  
EDWARD W. RICH      
Edward W. Rich, Vice President and Treasurer
(Principal Financial Officer)

2024



Union Carbide Corporation and Subsidiaries
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John R. Dearborn, President (Chief Executive Officer) of Union Carbide Corporation, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Union Carbide Corporation;

2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a)
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)
evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and

c)
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a)
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6.
The registrant's other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: October 30, 2002May 2, 2003 


 

/s/  
JOHN R. DEARBORN      
John R. Dearborn
President (Chief Executive Officer)

2125



Union Carbide Corporation and Subsidiaries
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Edward W. Rich, Vice President and Treasurer (Chief Financial Officer) of Union Carbide Corporation, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Union Carbide Corporation;

2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a)
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)
evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and

c)
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a)
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and
6.
The registrant's other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: October 30, 2002May 2, 2003 


 

/s/  
EDWARD W. RICH      
Edward W. Rich
Vice President and Treasurer (Chief
(Chief Financial Officer)

2226



EXHIBIT INDEX

EXHIBIT NO.

 DESCRIPTION

10.2310.28

 

Amended and Restated ServiceRevolving Credit Agreement, effectivedated as of July 1, 2002,March 25, 2003, between the Corporation and The Dow Chemical Company.

10.23.110.29

 

Service Addendum No. 1 to the ServicePledge and Security Agreement, effectivedated as of February 6, 2001,March 25, 2003, between the Corporation and The Dow Chemical Company.

10.23.223

 

Service Addendum No. 2 to the Service Agreement, effective as of August 1, 2001, between the Corporation and The Dow Chemical Company.

10.24


Amended and Restated Sales Promotion Agreement, effective as of September 13, 2002, between the Corporation and The Dow Chemical Company.

10.25


Agreement (to Provide Materials and Services), effective as of February 6, 2001, between the Corporation and Dow Hydrocarbons and Resources Inc.

10.25.1


Amendment to Agreement (to Provide Materials and Services), effective as of January 1, 2002.

10.26


Revolving Loan Agreement, effective as of February 6, 2001, between the Corporation and The Dow Chemical Company.

10.26.1


Revolving Loan Amendment No. 1, effective as of July 1, 2002, between the Corporation and The Dow Chemical Company.Analysis, Research & Planning Corporation's Consent.

99.1

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.2002.

99.2

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.2002.


QuickLinks

TABLE OF CONTENTSUnion Carbide Corporation Table of Contents
Union Carbide Corporation and Subsidiaries Consolidated Statements of Operations
Union Carbide Corporation and Subsidiaries Consolidated Balance Sheets
Union Carbide Corporation and Subsidiaries Consolidated Statements of Cash Flows
Union Carbide Corporation and Subsidiaries Consolidated Statements of Comprehensive Income
Union Carbide Corporation and Subsidiaries Notes to the Consolidated Financial Statements
SIGNATUREUnion Carbide Corporation and Subsidiaries Signatures
Union Carbide Corporation and Subsidiaries Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Union Carbide Corporation and Subsidiaries Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
EXHIBIT INDEX